U.S. FDA Determines Celliant® Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products

PureCare Creates Charitable Partnership With Boys’ Orphanage Reading U.S. FDA Determines Celliant® Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products 1 minute Next PureCare Donates Sleep Essentials to Hurricane Harvey Relief Efforts

Hologenix, LLC, maker of Celliant, the world's most advanced, clinically tested responsive textile technology, announced today that the U.S. Food and Drug Administration (FDA) has determined Celliant products are medical devices and general wellness products, as defined in Section 201(h) of the Federal Food, Drug and, Cosmetic Act.